Natalizumab. Treatment of IBD, Treatment of multiple sclerosis

被引：5
|
作者：
Sorbera, LA [1 ]
Martin, L [1 ]
Rabasseda, X [1 ]
机构：
[1] Prous Sci, Barcelona 08080, Spain
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 09期
关键词：
immunoglobulin G 4 (human-mouse monoclonal AN100226 gamma-chain anti-human integrin 4); disulfide with human-mouse; monoclonal AN100226 light chain; dimer;
D O I：
10.1358/dof.2000.025.09.593332
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：917 / 921
页数：5
相关论文
共 50 条
  • [21] Biomarkers for monitoring natalizumab treatment in multiple sclerosis
    Bringeland, G. H.
    Vedeler, C. A.
    Myhr, K. M.
    Gavasso, S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 901 - 901
  • [22] Disease Course in Multiple Sclerosis (MS) Patients Switching from Fingolimod to Natalizumab.
    Butzkueven, Helmut
    Kappos, Ludwig
    Trojano, Maria
    Chen, Yi
    Dong, Qunming
    Koendgen, Harold
    Belachew, Shibeshih
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 420 - 420
  • [23] Natalizumab in the treatment of patients with multiple sclerosis -: First experience
    Mareckova, Helena
    Havrdova, Eva
    Krasulova, Eva
    Vankova, Zdenka
    Koberova, Michaela
    Sterzl, Ivan
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 465 - 473
  • [24] The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
    Singer, Barry A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (09) : 327 - 336
  • [25] Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
    Tur, Carmen
    Tintore, Mar
    Vidal-Jordana, Angela
    Bichuetti, Denis
    Nieto Gonzalez, Pablo
    Jesus Arevalo, Maria
    Arrambide, Georgina
    Anglada, Elisenda
    Galan, Ingrid
    Castillo, Joaquin
    Jordi Rio, Carlos Nos
    Isabel Martin, Maria
    Comabella, Manuel
    Sastre-Garriga, Jaume
    Montalban, Xavier
    PLOS ONE, 2013, 8 (12):
  • [26] An audit evaluation of treatment with natalizumab in people with multiple sclerosis
    Holland, G.
    McDonald, K. R.
    Talbot, P.
    Rog, D. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S441 - S441
  • [27] Multiple sclerosis associated fatigue during natalizumab treatment
    Putzki, Norman
    Yaldizli, Oezguer
    Tettenborn, Barbara
    Diener, Hans Christoph
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 (1-2) : 109 - 113
  • [28] Natalizumab treatment in pediatric multiple sclerosis: A case report
    Borriello, Giovanna
    Prosperini, Luca
    Luchetti, Anna
    Pozzilli, Carlo
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (01) : 67 - 71
  • [29] Herpes encephalitis during natalizumab treatment in multiple sclerosis
    Kwiatkowski, A.
    Gallois, J.
    Bilbault, N.
    Calais, G.
    Mackowiak, A.
    Hautecoeur, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (06) : 909 - 911
  • [30] ECONOMIC EVALUATION OF NATALIZUMAB FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN MEXICO
    Reyes, A.
    Sanchez-Mejorada, G.
    Trejo, W.
    VALUE IN HEALTH, 2012, 15 (07) : A551 - A551
12345